Prognostic Impact of CD133 mRNA Expression in 48 Glioblastoma Patients Treated with Concomitant Radiochemotherapy: A Prospective Patient Cohort at a Single Institution

Philippe Metellus (1, 2) , Isabelle Nanni-Metellus (3) , Christine Delfino (2) , Carole Colin (2) , Aurelie Tchogandjian (2) , Béma Coulibaly (4) , Frederic Fina (3) , Anderson Loundou (5) , Marylin Barrie (6) , Olivier Chinot (6, 2) , L’houcine Ouafik (2, 3) , Dominique Figarella-Branger (2, 4)

1 Département de Neurochirurgie [CHU Timone]
2 CRO2 - Centre de Recherches en Oncologie biologique et Oncopharmacologie
3 Laboratoire de Transfert d'Oncologie Biologique [Hôpital Nord - APHM]
4 Service d'Anatomie Pathologique et de Neuropathologie
5 Unité d'Aide Méthodologique
6 Département de neurooncologie

Domains: Life Sciences [q-bio]; Cancer

Philippe Metellus, Isabelle Nanni-Metellus, Christine Delfino, Carole Colin, Aurelie Tchogandjian, et al.. Prognostic Impact of CD133 mRNA Expression in 48 Glioblastoma Patients Treated with Concomitant Radiochemotherapy: A Prospective Patient Cohort at a Single Institution. Annals of Surgical Oncology, 2011, 18 (10), pp.2937 - 2945. ⟨10.1245/s10434-011-1703-6⟩. ⟨hal-01827553⟩